arrow
F

Francesco Perri

IRCCS Fondazione G. Pascale
H指数:36
被引数:4,942

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Modern Pathology-Driven Strategies in Neoadjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma: From Residual Tumor Quantification to Spatial and AI-Based Biomarkers

《头颈鳞状细胞癌新辅助免疫治疗中的现代病理驱动策略:从残余肿瘤量化到空间及基于AI的生物标志物》

Cancers
IF4.4
2026-04-030
OAAI
Human papillomavirus 16 E6 oncoprotein promotes up-regulation of RNA-binding protein Sam68 in head and neck cancer

人乳头瘤病毒16 E6癌蛋白促进头颈癌中RNA结合蛋白Sam68的上调

2026-02-050
OA
Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer

头颈鳞状细胞癌老年患者西妥昔单抗联合放疗的回顾性试验

2025-11-020
OAAI
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers

遗传、流行病学、临床和治疗轨迹在结肠癌和直肠癌中的作用

2025-10-270
OAAI
Clinical and genetic drivers of oligo-metastatic disease in colon cancer

结肠癌寡转移性疾病的临床和遗传驱动因素

2025-02-010
OAAI
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization

自噬相关基因的多态性作为胰腺癌的易感性生物标志物: 对三个大型欧洲队列和功能特征的荟萃分析

2024-09-251
OA
A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic pancreatic cancer
2024-07-073
OAAI
Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk

PSCA rs2976395功能变异与胰腺癌风险的潜在关联

2024-06-263
PRE
A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma

多效性扫描发现胰腺导管腺癌的新易感位点

2024-05-011
OA
Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment
2024-04-221
OAAI
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

rs822336与C/ebp β 和NFIC的结合调节PD-L1表达的诱导并预测晚期NSCLC的anti-PD-1/PD-L1治疗

2024-03-257
OAAI
rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms

rs822336作为晚期NSCLC anti-PD-1/PD-L1免疫治疗的预测性生物标志物: 分子机制

2024-03-220
PRE
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer
2024-03-012
OAAI